| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/09/2002 | US6369083 2-methoxyimino-2 (pyrinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring |
| 04/09/2002 | US6369081 Muscarinic receptor agonists |
| 04/09/2002 | US6369080 Anticoagulant |
| 04/09/2002 | US6369077 Protease inhibitors |
| 04/09/2002 | US6369074 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists |
| 04/09/2002 | US6369072 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 04/09/2002 | US6369042 Radical-scavenging functions which counteract pathophysiological disorders especially connected with aging processes; also antidotes against organophosphorous compounds; vitamin b6 antagonists; wound healing promoters |
| 04/09/2002 | CA2229000C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 04/09/2002 | CA2071224C Quinoline derivatives, their production and use |
| 04/04/2002 | WO2002026891A1 Modified carbocyanine dyes and their conjugates |
| 04/04/2002 | WO2002026737A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| 04/04/2002 | WO2002026736A1 A thiazolidinedione derivative and its use as antidiabetic |
| 04/04/2002 | WO2002026735A1 Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026722A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026714A1 Spiro compounds |
| 04/04/2002 | WO2002026706A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors |
| 04/04/2002 | WO2001090097A3 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them |
| 04/04/2002 | WO2001089451A3 Protease inhibitors |
| 04/04/2002 | US20020040150 Skin treatment compositons containing a cationic polymer and a microparticle or nanoparticle vector |
| 04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
| 04/04/2002 | US20020040142 For therapy of bacterial diseases |
| 04/04/2002 | US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example |
| 04/04/2002 | US20020040022 Administering a therapeutically effective amount of a heterocyclic compound to the patient for the treatment of inosine monophosphate dehydrogenase associated disorders, such as allograft rejection |
| 04/04/2002 | US20020039998 Administering to human therapeutically effective amount of a combination of drug which is metabolized by cytochrome p450 monooxygenase or pharmaceutically acceptable salt thereof and ritonavir |
| 04/04/2002 | DE10044353A1 Unkompetitive Inhibitoren der Helikase-Primase Uncompetitive inhibitors of the helicase-primase |
| 04/04/2002 | CA2426117A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| 04/04/2002 | CA2423978A1 Potassium salt of thiazolidinedione and its use as antidiabetic |
| 04/04/2002 | CA2423975A1 Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/03/2002 | EP1193265A2 A process for the preparation of 4-[2-(aryl or heterocyclo)-1H-imidazol-1-yl]benzenesulfonamides |
| 04/03/2002 | EP1193261A1 New thiadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 04/03/2002 | EP1192151A1 Anilinoquinazolines as protein tyrosine kinase inhibitors |
| 04/03/2002 | EP1192144A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids |
| 04/03/2002 | EP1192143A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 04/03/2002 | EP1192142A1 Cyclo-imino depsipeptides and their utilization in controlling endoparasites |
| 04/03/2002 | EP1192135A2 Serine protease inhibitors |
| 04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1192129A2 Pharmaceutical compounds |
| 04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1158980A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1156807A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1140087A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | CN1342650A Process for refining meloxicam |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365748 Method for preparing lintitript potassium salt |
| 04/02/2002 | US6365747 Method for the preparation of citalopram |
| 04/02/2002 | US6365613 Fungicidal mixtures |
| 04/02/2002 | US6365612 Benzosultam oxazolidinone antibacterial agents |
| 04/02/2002 | US6365607 Thiazolidinedione and oxazolidinedione compounds for treatment of diabetic anemia, edema, and anorexia |
| 04/02/2002 | US6365606 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
| 04/02/2002 | US6365603 Aromatic compounds and pharmaceutical compositions containing them |
| 04/02/2002 | US6365602 For therapy of depression, anxiety, asthma, pain, inflammation, urinary incontinence and other disease conditions |
| 04/02/2002 | US6365588 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365335 Sensitivity and decreased in residual color |
| 04/02/2002 | US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 04/02/2002 | CA2223574C Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein b (apo b) secretion |
| 04/02/2002 | CA2220276C Substituted thiophene derivative and plant disease control agent comprising the same as active ingredient |
| 04/02/2002 | CA2099868C Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| 04/02/2002 | CA2097928C Uracil derivatives |
| 03/28/2002 | WO2002024691A1 Thiazole derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides |
| 03/28/2002 | WO2002024689A1 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis |
| 03/28/2002 | WO2002024687A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
| 03/28/2002 | WO2002024686A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024682A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/28/2002 | WO2002024681A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024646A1 Delta1-pyrrolines used as pesticides |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024200A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 03/28/2002 | WO2000066102A3 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| 03/28/2002 | US20020038034 Intermediates for the preparation of 2-imidazolin-5-ones |
| 03/28/2002 | US20020037924 Small molecule carbamate or urea hair growth compositions and uses |
| 03/28/2002 | US20020037915 4-(4-(1- phenyl-5-propylpyrazol4-yl)(1,3-thiazol-2-yl))-5-methylthiothiophene-2 -carboxamidine, for example; complement inhibitors; treating tissue damage, inflammation, or autoimmune diseases |
| 03/28/2002 | US20020037901 5-((2,4-bis-(4-methylphenylmethoxy)phenyl)methylene)-4-oxo-2-thioxo-3 -thiazolidineacetic acid, for example; treatment and prophylaxis of tumors and tumor metastasis |
| 03/28/2002 | US20020037886 Muscarinic agonists |
| 03/28/2002 | DE10038436A1 New 5-acceptor-functionalized 2-diarylamino thiophene or thiazole derivatives, especially useful for making organic light-emitting diodes |
| 03/28/2002 | CA2423156A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | CA2423050A1 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | CA2418208A1 Compounds having fungicidal activity and processeses to make and use same |
| 03/27/2002 | EP1191024A1 Thiadiazines and their use as inhibitors of metalloproteinases |
| 03/27/2002 | EP1191019A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof |
| 03/27/2002 | EP1189902A1 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist |
| 03/27/2002 | EP1189895A1 Thiazole and oxazole derivatives and their pharmaceutical use |
| 03/27/2002 | EP1189894A1 Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer |
| 03/27/2002 | EP1189893A2 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one |
| 03/27/2002 | EP1189888A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS $i(PDE 4) INHIBITORS |
| 03/27/2002 | EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
| 03/27/2002 | EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
| 03/27/2002 | EP1189583A1 Indole derivatives |
| 03/27/2002 | EP0799056B1 Use of a nk-1 receptor antagonist and an opioid analgesic |
| 03/27/2002 | CN1342159A Process for preparation of 6-(perfluoroalkyl) uracil compounds |
| 03/27/2002 | CN1342158A 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |